Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Stanley T. Crooke, Raúl D. Santos et al.|The Lancet|2010Cited by 905
Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant.Daniel Finley, Vincent Chau, Paul J. Rice-Boucher et al.|Molecular and Cellular Biology|1994Cited by 354
Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic miceMark J. Graham, Rosanne M. Crooke, Kristina M. Lemonidis et al.|Journal of Lipid Research|2007Cited by 291
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A. Anderson, Punit P. Seth, Graeme C. Freestone et al.|Nucleic Acids Research|2021Cited by 129
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotidesMichael E. Østergaard, Punit P. Seth, Cheryl Li De Hoyos et al.|Nucleic Acids Research|2020Cited by 98